Abstract:Pyridoxine (pyr) is a versatile molecule that forms part of the family of B vitamins. It is used to treat and prevent vitamin B6 deficiency and certain types of metabolic disorders. Moreover, the pyridoxine molecule has been investigated as a suitable ligand toward metal ions. Nevertheless, the study of the magnetic properties of metal complexes containing lanthanide(III) ions and this biomolecule is unexplored. We have synthesized and characterized a novel pyridoxine-based GdIII complex of formula [GdIII(pyr)2(H2O)4]Cl3 · 2 H2O (1) [pyr = pyridoxine]. 1 crystallizes in the triclinic system and space group Pī. In its crystal packing, cationic [Gd(pyr)2(H2O)4]3+ entities are connected through H-bonding interactions involving non-coordinating water molecules and chloride anions. In addition, Hirshfeld surfaces of 1 were calculated to further investigate their intermolecular interactions in the crystal lattice. Our investigation of the magnetic properties of 1, through ac magnetic susceptibility measurements, reveals the occurrence of a slow relaxation in magnetization in this mononuclear GdIII complex, indicating an unusual single-ion magnet (SIM) behavior for this pseudo-isotropic metal ion at very low temperatures. We also studied the relaxometric properties of 1, as a potential contrast agent for high-field magnetic resonance imaging (MRI), from solutions of 1 prepared in physiological serum (0.0–3.2 mM range) and measured at 3 T on a clinical MRI scanner. The values of relaxivity obtained for 1 are larger than those of some commercial MRI contrast agents based on mononuclear GdIII systems.

Chemical Synthesis of Paramagnetic Complexes

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents

Evaluation of Structurally Related Acyclic Ligands OBETA, EHDTA, and EGTA for Stable Mn2+ Complex Formation

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Hydrothermal synthesis of a highly sensitive T2-weigthed MRI contrast agent: zinc-doped superparamagnetic iron oxide nanocrystals.

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents

Synthesis and Evaluation of Bingel-Hirsch Multiadducts of Paramagnetic Gadofullerene As Potential Magnetic Resonance Imaging Contrast Agents.

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Gd(III) complex conjugated ultra-small iron oxide as an enhanced T1-weighted MR imaging contrast agent

Controlled Synthesis Of Mnfe2o4 Nanoparticles And Gd Complex-Based Nanocomposites As Tunable And Enhanced T-1/T-2-Weighted Mri Contrast Agents

Divalent Manganese Complexes as Potential Replacements for Gadolinium-Based Contrast Agents

Synthesis and Characterization of a New Water-Soluble Endohedral Metallofullerene for MRI Contrast Agents

Controlled Self-Assembling Of Gadolinium Nanoparticles As Smart Molecular Magnetic Resonance Imaging Contrast Agents

A Gadolinium(III) Complex Based on Pyridoxine Molecule with Single-Ion Magnet and Magnetic Resonance Imaging Properties

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents

Design and synthesis of chiral DOTA-based MRI contrast agents with remarkable relaxivities

α-Aryl Substituted GdDOTA Derivatives, the Perfect Contrast Agents for MRI?

Synthesis and in Vitro and in Vivo Evaluation of Manganese(Iii) Porphyrin-Dextran As A Novel Mri Contrast Agent